Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment

Hepatocellular carcinoma (HCC) is one of the most common malignancies today. Patients suffer from HCC since its high malignancy and limited treatment means. With the development of genetic research, new therapeutic strategy comes up in the way of gene editing. Clustered regularly interspaced short p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoling, Ma, Weijie, Mei, Chengjie, Chen, Xi, Yao, Ye, Liu, Yingyi, Qin, Xian, Yuan, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268395/
https://www.ncbi.nlm.nih.gov/pubmed/32487115
http://dx.doi.org/10.1186/s13046-020-01603-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268395/
https://www.ncbi.nlm.nih.gov/pubmed/32487115
http://dx.doi.org/10.1186/s13046-020-01603-0

Ejemplares similares